Table 5.

Pooled Summary Odds Estimates for Type-Specific Protection Associated With Baseline L1 Seropositivity for All 8 Human Papillomavirus (HPV) Types Examined

Outcome Definition	ORa (95% CI)
All 8 genotypes
HPV DNA positive at any 2 follow-up visits	0.97 (.80–1.17)
HPV DNA positive at 2 sequential follow-up visits	0.77 (.54–1.09)
HPV16 and HPV18 combined
HPV DNA positive at any 2 follow-up visits	0.78 (.56–1.08)
HPV DNA positive at 2 sequential follow-up visits	0.38 (.18–.78)

Data are adjusted for report of a new sex partner during the trial period.

Abbreviations: CI, confidence interval; OR, odds ratio.

^a For L1 seropositivity.